Hodgkin Lymphoma

• CLINICAL_TRIALS withdrawal · 2024-10-24
  Clinical Trial Update: Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas [Phase 1, Phase 2]

  Clinical trial evaluating FE 203799 in adults with lymphomas has been withdrawn. The study examined safety, tolerability, and PK/PD in Phase…

• CLINICAL_TRIALS withdrawal · 2024-10-22
  Clinical Trial Update: (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). [Phase 1]

  Phase 1 pediatric lymphoma trial evaluating pediTACTAL TAA-specific cytotoxic T-lymphocytes has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-07-08
  Clinical Trial Update: GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma [Phase 1, Phase 2]

  The GEMHDM2014 trial evaluating Gem-HDM HDT and autologous stem cell transplant for relapsed/refractory lymphoma has been terminated after P…

• CLINICAL_TRIALS withdrawal · 2021-02-15
  Clinical Trial Update: Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) [Phase 3]

  A Phase 3 clinical trial for very early FDG-PET/CT-response adapted therapy in advanced Hodgkin lymphoma was withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-11-29
  Clinical Trial Update: Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]

  Phase 2 trial evaluating specially treated stem cells for peripheral stem cell transplantation in patients with Non-Hodgkin lymphoma or Hodg…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2017-06-27
  Clinical Trial Update: Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [Phase 1, Phase 2]

  The Phase 1/2 trial assessing pembrolizumab in combination with chemotherapy for advanced lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2016-12-15
  Clinical Trial Update: Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 2]

  Phase 2 trial of rituximab, gemcitabine, and vinorelbine for Hodgkin lymphoma that relapsed or did not respond to prior therapy has been wit…

• CLINICAL_TRIALS withdrawal · 2016-11-08
  Clinical Trial Update: Prospective Study of Lymphoproliferative Diseases

  This clinical trial update notes that the prospective study of lymphoproliferative diseases sponsored by West Virginia University has been w…

• CLINICAL_TRIALS withdrawal · 2016-11-01
  Clinical Trial Update: Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant [Phase 2]

  A Phase II trial evaluating an EBV-derived dendritic cell vaccine in autologous stem cell transplantation for Hodgkin lymphoma and non-Hodgk…

• CLINICAL_TRIALS withdrawal · 2016-07-14
  Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]

  A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…

• CLINICAL_TRIALS withdrawal · 2015-11-20
  Clinical Trial Update: Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors [NA]

  This trial evaluating dietary and exercise interventions to prevent cardiovascular disease in young survivors of childhood cancers (brain tu…

• CLINICAL_TRIALS withdrawal · 2012-07-09
  Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]

  A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…

• CLINICAL_TRIALS withdrawal · 2012-05-10
  Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]

  A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-03-16
  Clinical Trial Update: Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma [NA]

  A clinical trial evaluating fludarabine and cyclophosphamide followed by LMB-2 immunotoxin for Hodgkin lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-02-23
  Clinical Trial Update: Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy [Phase 1]

  Phase 1 safety study of a PD-L1 inhibitor sponsored by Bristol-Myers Squibb has been withdrawn. The study targeted hematologic malignancies …

• CLINICAL_TRIALS withdrawal · 2012-02-20
  Clinical Trial Update: Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease [Phase 2]

  A Phase 2 trial of liposomal tretinoin for recurrent or refractory Hodgkin lymphoma has been withdrawn.